Secondary xanthomata in systemic diseases — the xanthomata associated with cholestatic liver disease, hypothyroidism, diabetes, nephrotic syndrome, and dysproteinaemias representing disease-specific xanthoma management requiring different approaches from primary hyperlipidemic xanthomata — creates important clinical market dimensions within the overall xanthoma market, with the...